<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01406652</url>
  </required_header>
  <id_info>
    <org_study_id>11-016 (NAC 11-004)</org_study_id>
    <nct_id>NCT01406652</nct_id>
  </id_info>
  <brief_title>Optimisation of the Treatment of Infectious Bursitis</brief_title>
  <official_title>One-stage Versus Two-stage Surgical Treatment of Infectious Bursitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates prospectively the cost-savings related to a one-stage bursectomy
      (debridement, drainage and closure at the same time) versus two-stage bursectomy
      (debridement, left open and closure at a second time) of severe bursitis among hospitalized
      patients for surgical treatment of septic bursitis.

      We suppose that the one-stage bursectomy reveals similar recurrence rates but is associated
      with a significant shortening of hospital stay, consumption of resources and increased
      patient satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Start as single center interventional study at Geneva University Hospitals Study open for
      additional centres (electronic CRF) Funding on 24.6.2011 (50,000 Swiss Francs). Further
      demand for funding ongoing.

      Septic bursitis of knee and elbows, for which the patients are hospitalised (a substantial
      part of patient with failure of conservative treatment) Randomisation 1:1 (one-stage vs.
      two-stage).

      Duration of concomitant postsurgical antibiotic therapy fixed to 7 days Exclusion of severely
      immuno-depressed patients.

      Assessment of all costs of inpatient treatment and outpatient follow-up of included cases.

      Interim analysis after ca. 100 cases planified.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Randomization 1:1 with two arms: One versus two-stage bursectomy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Costs of the Combined Surgical and Medical Treatment</measure>
    <time_frame>2 months</time_frame>
    <description>The overall costs are of primary interest in the study protocol.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Post-surgical Wound Dehiscence</measure>
    <time_frame>2 months</time_frame>
    <description>We assess clinical failures of bursectomy for bursitis. As recurrences are associated with wound dehiscence, we evaluate the dehiscence a the most important parameter for Failure. Of course, dehiscence can also occur without recurrent infection, but this is also considered as failure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Olecranon Bursitis</condition>
  <condition>Patellar Bursitis</condition>
  <arm_group>
    <arm_group_label>One-stage bursectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bursectomy with debridement and primary closure of the wound during one surgical intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two-stage bursectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bursectomy with debridement and left open. Wound closure in a second step and in a second surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Two-stage bursectomy</intervention_name>
    <description>Debridement, drainage, and secondary closure of septic bursitis during two surgical interventions</description>
    <arm_group_label>One-stage bursectomy</arm_group_label>
    <arm_group_label>Two-stage bursectomy</arm_group_label>
    <other_name>There are no &quot;other names&quot;</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;18 years

          2. Hospitalized for bursectomy for septic bursitis

        Exclusion Criteria:

          1. Bacteraemic diseases

          2. Presence of another concomitant infection requiring antibiotics

          3. Presence of osteosynthesis material beneath the bursitis

          4. Septic bursitis outside of the elbow or the knee

          5. Severe immune suppression (transplantation, HIV with Cluster of Differentiation cell
             count &lt;200 cells/mm3, immune suppressive treatment with equivalence of more than 15 mg
             of prednisone daily ).

          6. Recurrent septic bursitis episodes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilker UCKAY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Perez C, Huttner A, Assal M, Bernard L, Lew D, Hoffmeyer P, Uçkay I. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010 May;65(5):1008-14. doi: 10.1093/jac/dkq043. Epub 2010 Mar 1.</citation>
    <PMID>20197288</PMID>
  </reference>
  <reference>
    <citation>Uçkay I, von Dach E, Perez C, Agostinho A, Garnerin P, Lipsky BA, Hoffmeyer P, Pittet D. One- vs 2-Stage Bursectomy for Septic Olecranon and Prepatellar Bursitis: A Prospective Randomized Trial. Mayo Clin Proc. 2017 Jul;92(7):1061-1069. doi: 10.1016/j.mayocp.2017.03.011. Epub 2017 Jun 8.</citation>
    <PMID>28602435</PMID>
  </reference>
  <reference>
    <citation>Baumbach SF, Wyen H, Perez C, Kanz KG, Uçkay I. Evaluation of current treatment regimens for prepatellar and olecranon bursitis in Switzerland. Eur J Trauma Emerg Surg. 2013 Feb;39(1):65-72. doi: 10.1007/s00068-012-0236-4. Epub 2012 Nov 8.</citation>
    <PMID>26814924</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 27, 2011</study_first_submitted>
  <study_first_submitted_qc>July 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2011</study_first_posted>
  <results_first_submitted>January 16, 2017</results_first_submitted>
  <results_first_submitted_qc>November 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 5, 2019</results_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Ilker Uckay</investigator_full_name>
    <investigator_title>PD Dr. med, MD, Attending</investigator_title>
  </responsible_party>
  <keyword>septic bursitis</keyword>
  <keyword>bursectomy</keyword>
  <keyword>primary closure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>See below</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>One-stage Bursectomy</title>
          <description>79 patients undergo surgical bursectomy and wound closure within the same Operation.</description>
        </group>
        <group group_id="P2">
          <title>Two-stage Bursectomy</title>
          <description>85 patients have a two-stage Approach. First, they undergo surgical bursectomy with the wound left open. In a second step 3-4 days later, they are re-operated for wound closure.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="109"/>
                <participants group_id="P2" count="115"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
                <participants group_id="P2" count="95"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost-to-follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Insufficient follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Infection not sure</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>One-stage Bursectomy</title>
          <description>Bursectomy with debridement and primary closure of the wound during one surgical intervention</description>
        </group>
        <group group_id="B2">
          <title>Two-stage Bursectomy</title>
          <description>Two-stage bursectomy: Debridement, drainage, and secondary closure of septic bursitis during two surgical interventions</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="79"/>
            <count group_id="B2" value="85"/>
            <count group_id="B3" value="164"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="150"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" lower_limit="18" upper_limit="94"/>
                    <measurement group_id="B2" value="51" lower_limit="20" upper_limit="86"/>
                    <measurement group_id="B3" value="52" lower_limit="18" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="164"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Costs of the Combined Surgical and Medical Treatment</title>
        <description>The overall costs are of primary interest in the study protocol.</description>
        <time_frame>2 months</time_frame>
        <population>The overall costs (Swiss francs; CHF) are of primary interest in the study protocol</population>
        <group_list>
          <group group_id="O1">
            <title>One-stage Bursectomy</title>
            <description>Total costs in Swiss francs of the one-stage bursectomy approach and associated treatment.</description>
          </group>
          <group group_id="O2">
            <title>Two-stage Bursectomy</title>
            <description>Total costs in Swiss francs of the one-stage bursectomy approach and associated treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Costs of the Combined Surgical and Medical Treatment</title>
          <description>The overall costs are of primary interest in the study protocol.</description>
          <population>The overall costs (Swiss francs; CHF) are of primary interest in the study protocol</population>
          <units>Swiss Francs</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="85"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6881" lower_limit="4587" upper_limit="8254"/>
                    <measurement group_id="O2" value="11178" lower_limit="9231" upper_limit="12498"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Post-surgical Wound Dehiscence</title>
        <description>We assess clinical failures of bursectomy for bursitis. As recurrences are associated with wound dehiscence, we evaluate the dehiscence a the most important parameter for Failure. Of course, dehiscence can also occur without recurrent infection, but this is also considered as failure.</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One-stage Bursectomy</title>
            <description>Bursectomy with debridement and primary closure of the wound during one surgical intervention</description>
          </group>
          <group group_id="O2">
            <title>Two-stage Bursectomy</title>
            <description>Two-stage bursectomy: Debridement, drainage, and secondary closure of septic bursitis during two surgical interventions</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Post-surgical Wound Dehiscence</title>
          <description>We assess clinical failures of bursectomy for bursitis. As recurrences are associated with wound dehiscence, we evaluate the dehiscence a the most important parameter for Failure. Of course, dehiscence can also occur without recurrent infection, but this is also considered as failure.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="85"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months post surgical follow-up</time_frame>
      <group_list>
        <group group_id="E1">
          <title>One-versus Bursectomy</title>
          <description>Bursectomy and surgical wound closure during the same surgery</description>
        </group>
        <group group_id="E2">
          <title>Two-stage Busectomy</title>
          <description>Bursectomy during the first surgery, followed by a surgical closure in a second step.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="85"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="85"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="85"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Handicap</sub_title>
                <description>Persistant postsurgical pain</description>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="79"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="85"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr.med Ilker Uçkay</name_or_title>
      <organization>Geneva University Hospitals</organization>
      <phone>+412237123311</phone>
      <email>ilker.uckay@hcuge.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

